This article was originally published on Jan. 19.

By Ben Butkus

Nucleic acid testing of blood donations revealed a higher-than-expected rate of hepatitis B infection in donors, including those who had been previously vaccinated and who would not have been identified by routine antibody screening, according to results of one of the largest clinical trials of nucleic acid testing conducted to date.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.